Aspirin reduces lipopolysaccharide-induced pulmonary inflammation in human models of ARDS. [electronic resource]
Producer: 20171116Description: 971-980 p. digitalISSN:- 1468-3296
- Adult
- Anti-Inflammatory Agents, Non-Steroidal -- therapeutic use
- Aspirin -- therapeutic use
- Biomarkers -- metabolism
- Bronchoalveolar Lavage
- C-Reactive Protein -- immunology
- Cytokines -- immunology
- Double-Blind Method
- Female
- Humans
- Inflammation -- drug therapy
- Inhalation
- Interleukin-8 -- immunology
- Lipopolysaccharides -- administration & dosage
- Male
- Neutrophils -- immunology
- Prospective Studies
- Respiratory Distress Syndrome -- diagnosis
- Treatment Outcome
- Volunteers
No physical items for this record
Publication Type: Journal Article; Randomized Controlled Trial
There are no comments on this title.
Log in to your account to post a comment.